✦ LIBER ✦

Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia

✍ Scribed by Michele Baccarani; Alfonso Zaccaria; Giuseppe Bandini; Giovanna Cavazzini; Renato Fanin; Sante Tura

Book ID: 113238205
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 484 KB
Volume: 7
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(83)90048-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of acute myeloid leukemia deve

Treatment of acute myeloid leukemia developing after a myelodysplastic phase with low dose arabinosyl cytosine

✍ Anthony D. Ho; C.Eberhard Schwarz; Werner Hunstein 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Low-dose arabinosyl cytosine in acute le

Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia

✍ Emilio P. Alessandrino; Ester Orlandi; Ercole Brusamolino; Mario Lazzarino; Carl 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

Low dose cytosine arabinoside in the tre

Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes

✍ M. Murray; P. Sarsfield; E. Lawlor; S. R. McCann 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 337 KB

Low-dose cytosine-arabinoside in the tre

Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

✍ Weh, H. J. ;Zschaber, R. ;Hossfeld, D. K. 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 189 KB

Low-dose cytosine arabinoside in the mye

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre

Low-dose cytosine arabinoside (Ara-C) th

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia

✍ Jane N. Winter; Daina Variakojis; Ellen R. Gaynor; Richard A. Larson; Kenneth B. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB